<DOC>
	<DOC>NCT00850889</DOC>
	<brief_summary>Comparison of the safety and effectiveness of Juvederm Ultra with lidocaine compared with Restylane in the correction of nasolabial folds.</brief_summary>
	<brief_title>Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds</brief_title>
	<detailed_description />
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Desires correction of moderate to severe nasolabial folds (NLFs) Both NLFs have the same pretreatment NLF severity score (either moderate or severe) Females of childbearing potential must have a negative urine pregnancy test result at baseline and practice a reliable method of contraception throughout the study Cosmetic facial procedures [e.g., facelift, resurfacing (laser, photomodulation, intense pulsed light, radio frequency, dermabrasion, chemical peel or other ablative or nonablative procedures), tissue augmentation with dermal fillers or fat injections, BOTOX Cosmetic injections, or mesotherapy] in the lower 2/3 of the face, including the neck, within 1 month prior to study entry or be planning to undergo any of these procedures at any time during the study Initiating use of any new overthecounter or prescription, oral or topical, antiwrinkle products in the NLF area within 1 month prior to enrollment or during the study Previous hyaluronic acid (HA)based dermal filler treatment(s) injected within the last 12 months prior to enrollment is within 5mL of the recommended annual maximum volume for HA dermal fillers Previous injection of semipermanent fillers or placement of facial implants anywhere in the head and neck or implantation of any of these products during the study Allergy or sensitivity to lidocaine, hyaluronic acid products, or Streptococcal protein Active inflammation, infection, cancerous or precancerous lesion or unhealed wound in the NLF region Current treatment with anticoagulation therapy or use of nonsteroidal antiinflammatory drugs or other substances known to increase coagulation time within 10 days of undergoing study injections</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Aesthetic correction of nasolabial folds</keyword>
</DOC>